Protonitazene

CAS 95958-84-2

Protonitazene illustrates why identical formulas can conceal different structures. CAS 95958-84-2 identifies the free base with a normal-propoxy group, distinct from isotonitazene's branched group. A 2023 study separated the isomers chromatographically before tandem mass-spectrometric detection, showing how separation adds information beyond mass alone. A 2024 clinical report detected protonitazene in two investigated cases involving products represented as tetrahydrocannabinol vapes. These findings support precise analytical and toxicological monitoring without defining every product in that category. Free-base identity, salt form, sample evidence, and clinical context remain separate parts of interpretation. The compound's story connects a small structural difference with the practical need to establish exactly which substance is present, rather than relying on a family name or a single shared analytical signal.